Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Wednesday Pre-Market Insights: GEVO, WPZ, HDP, PTIE

Published 05/13/2015, 07:51 AM
Updated 05/14/2017, 06:45 AM


Gevo Inc (NASDAQ:GEVO) shares are up more than 21% in pre-market trading to $5.68 after the renewable chemicals and advanced biofuels company reported 1Q15 results. Gevo posted quarterly revenue of $5.9 million, a significant increase from $0.9 million in the same quarter of last year. The report also highlighted a recent renewable jet fuel agreement with Alaska Air Group Inc (NYSE:ALK).


Williams Partners LP (NYSE:WPZ) is up nearly 15% to $54.40 per share following an announcement that all public equity of the natural gas company will be bought by Williams Companies Inc (NYSE:WMB). Before the buyout, Williams owned 60% of WPZ. Furthermore, WPZ will raise its 3Q dividend to $0.64 and tells investors to expect a 10% to 15% annual dividend growth through 2020.

Hortonworks Inc (NASDAQ:HDP) shares increased 12.78% to $4.50 per share following 1Q15 earnings. The California-based computer software company reported strong revenue of $22.8 million, which is triple the figure from the same quarter of last year. Much of the quarterly revenue came from Hadoop, the company’s data-capturing technology.

Pain Therapeutics (NASDAQ:PTIE) jumped more than 8.5% to $2.85 in pre-market trading after new data from a recent study revealed that Remoxy, the biotechnology company’s lead pipeline product, could be a less-addictive painkiller due to its high viscosity. Remoxy is currently in Phase III testing.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.